Standout Papers

Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma 2021 2026 2022 2024216
  1. Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma (2021)
    Mehmet Samur, Mariateresa Fulciniti et al. Nature Communications

Immediate Impact

15 from Science/Nature 73 standout
Sub-graph 1 of 23

Citing Papers

Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors
2025 Standout
Novel strategies to manage CAR-T cell toxicity
2025 Standout
3 intermediate papers

Works of A. Alonso being referenced

Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma
2021 Standout

Author Peers

Author Last Decade Papers Cites
A. Alonso 9 185 11 111 101 8 252
Patricia Quade-Lyssy 16 119 15 139 70 9 319
Weston Sutherland 10 153 16 90 116 7 335
Walid Warda 3 120 3 81 41 8 206
Bryan Do 8 177 11 48 28 7 276
Hsin‐Yuan Cheng 47 121 9 145 32 14 324
Xiaoqian Liang 5 231 7 111 19 8 317
Vanessa D. Jönsson 8 93 8 165 38 10 293
Paul Shafer 6 183 4 78 28 8 261
Ashley Turka 247 1 140 135 7 280
Abigail Hamilton 14 36 13 212 72 8 325

All Works

Loading papers...

Rankless by CCL
2026